• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌中的基质金属蛋白酶及其抑制剂

Matrix metalloproteinases and their inhibitors in gastric cancer.

作者信息

Murray G I, Duncan M E, Arbuckle E, Melvin W T, Fothergill J E

机构信息

Department of Pathology, University of Aberdeen, UK.

出版信息

Gut. 1998 Dec;43(6):791-7. doi: 10.1136/gut.43.6.791.

DOI:10.1136/gut.43.6.791
PMID:9824606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1727341/
Abstract

BACKGROUND

The matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) are strongly implicated in tumour invasion and metastasis.

AIMS

To investigate the presence of individual MMPs and TIMPs in gastric cancer.

METHODS

The presence of MMP-1, MMP-2, MMP-3, MMP-9, TIMP-1, and TIMP-2 was identified in a group of gastric cancers (n=74) by immunohistochemistry using monoclonal antibodies. These antibodies were effective on formalin fixed, paraffin wax embedded sections.

RESULTS

A large proportion (94%) of gastric cancers contained MMP-2; MMP-1 and MMP-9 were also detected in 73% and 70% of tumours respectively. MMP-3 was only present in 27% of tumours. MMP-1 and MMP-9 were found predominantly in intestinal type tumours. TIMP-1 and TIMP-2 were identified in 41% and 57% of tumours respectively. Immunoreactivity for individual MMPs or TIMPs was not identified in normal stomach.

CONCLUSIONS

This study shows the presence of matrix metalloproteinases, particularly MMP-2, and TIMPs in stomach cancer. Antibodies which are effective in formalin fixed, paraffin wax embedded sections are useful for the identification of MMPs and TIMPs in diagnostic specimens.

摘要

背景

基质金属蛋白酶(MMPs)和基质金属蛋白酶组织抑制剂(TIMPs)与肿瘤侵袭和转移密切相关。

目的

研究胃癌中单个MMPs和TIMPs的存在情况。

方法

使用单克隆抗体通过免疫组织化学在一组胃癌(n = 74)中鉴定MMP - 1、MMP - 2、MMP - 3、MMP - 9、TIMP - 1和TIMP - 2的存在。这些抗体对福尔马林固定、石蜡包埋切片有效。

结果

很大比例(94%)的胃癌含有MMP - 2;分别在73%和70%的肿瘤中也检测到MMP - 1和MMP - 9。MMP - 3仅存在于27%的肿瘤中。MMP - 1和MMP - 9主要在肠型肿瘤中发现。分别在41%和57%的肿瘤中鉴定出TIMP - 1和TIMP - 2。在正常胃中未发现单个MMPs或TIMPs的免疫反应性。

结论

本研究表明胃癌中存在基质金属蛋白酶,尤其是MMP - 2,以及TIMPs。对福尔马林固定、石蜡包埋切片有效的抗体可用于在诊断标本中鉴定MMPs和TIMPs。

相似文献

1
Matrix metalloproteinases and their inhibitors in gastric cancer.胃癌中的基质金属蛋白酶及其抑制剂
Gut. 1998 Dec;43(6):791-7. doi: 10.1136/gut.43.6.791.
2
[Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study].[通过免疫组织化学研究分析快速破坏性髋关节炎(RDC)关节组织中基质金属蛋白酶(MMPs)和金属蛋白酶组织抑制剂(TIMPs)的表达]
Ryumachi. 1997 Oct;37(5):688-95.
3
The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer.基质金属蛋白酶和金属蛋白酶组织抑制剂在结直肠癌中的分布
Surg Oncol. 1995;4(2):111-9. doi: 10.1016/s0960-7404(10)80015-5.
4
Matrix metalloproteinases and their inhibitors.基质金属蛋白酶及其抑制剂。
Anticancer Res. 1999 Mar-Apr;19(2C):1589-92.
5
Secretion of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases into the intrauterine compartments during early pregnancy.妊娠早期基质金属蛋白酶-2、基质金属蛋白酶-9及金属蛋白酶组织抑制剂向子宫内各腔隙的分泌。
Mol Hum Reprod. 1999 Apr;5(4):376-81. doi: 10.1093/molehr/5.4.376.
6
Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.与周围非肿瘤组织相比,基质金属蛋白酶(MMPs)和金属蛋白酶组织抑制剂(TIMPs)在肝细胞癌组织中的表达情况。
Res Commun Mol Pathol Pharmacol. 2004;115-116:143-50.
7
Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.免疫反应性基质金属蛋白酶和基质金属蛋白酶组织抑制剂在人正常肝脏和原发性肝肿瘤中的表达。
Hepatology. 1996 Jun;23(6):1341-4. doi: 10.1053/jhep.1996.v23.pm0008675149.
8
Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.实验性胆汁性肝纤维化中基质金属蛋白酶及其抑制剂之间的平衡改变
Am J Pathol. 1998 Dec;153(6):1895-902. doi: 10.1016/S0002-9440(10)65703-3.
9
Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum.金属蛋白酶及其抑制剂在出生后发育中的大鼠小脑中的时空表达模式。
J Neurosci. 1999 Jun 15;19(12):4994-5004. doi: 10.1523/JNEUROSCI.19-12-04994.1999.
10
Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain.基质金属蛋白酶和金属蛋白酶组织抑制因子与大鼠脑再灌注后的血脑屏障开放有关。
Stroke. 1998 Oct;29(10):2189-95. doi: 10.1161/01.str.29.10.2189.

引用本文的文献

1
Mimicking Gastric Cancer Collagen Reorganization with Decellularized ECM-Based Scaffolds.利用基于脱细胞细胞外基质的支架模拟胃癌的胶原重组
Biology (Basel). 2025 Aug 16;14(8):1067. doi: 10.3390/biology14081067.
2
Exploring the potential of machine learning in gastric cancer: prognostic biomarkers, subtyping, and stratification.探索机器学习在胃癌中的潜力:预后生物标志物、亚型分类及分层
BMC Cancer. 2025 Apr 30;25(1):809. doi: 10.1186/s12885-025-14204-x.
3
High expression of ABL2 promotes gastric cancer cells migration, invasion and proliferation via the TGF-β and YAP signaling pathways.ABL2的高表达通过TGF-β和YAP信号通路促进胃癌细胞的迁移、侵袭和增殖。
J Cancer. 2024 Sep 9;15(17):5719-5728. doi: 10.7150/jca.99307. eCollection 2024.
4
Roles of ubiquitination in the crosstalk between tumors and the tumor microenvironment (Review).泛素化在肿瘤与肿瘤微环境相互作用中的作用(综述)。
Int J Oncol. 2022 Jul;61(1). doi: 10.3892/ijo.2022.5374. Epub 2022 May 26.
5
Matrix Metalloproteinases in -Associated Gastritis and Gastric Cancer.基质金属蛋白酶与相关性胃炎和胃癌。
Int J Mol Sci. 2022 Feb 8;23(3):1883. doi: 10.3390/ijms23031883.
6
The changing face of gastric cancer: epidemiologic trends and advances in novel therapies.胃癌的变化面貌:流行病学趋势与新型疗法的进展
Cancer Gene Ther. 2021 May;28(5):390-399. doi: 10.1038/s41417-020-00234-z. Epub 2020 Oct 2.
7
Polymorphisms in , , and do not contribute to breast, lung and colon cancer risk in polish population.、、和基因的多态性与波兰人群患乳腺癌、肺癌和结肠癌的风险无关。
Hered Cancer Clin Pract. 2020 Jul 31;18:16. doi: 10.1186/s13053-020-00147-w. eCollection 2020.
8
JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis.JP3 是一种抗血管生成肽,通过 TRIM25/SP1/MMP2 轴抑制胃癌的生长和转移。
J Exp Clin Cancer Res. 2020 Jun 23;39(1):118. doi: 10.1186/s13046-020-01617-8.
9
A targeted proteomics approach reveals a serum protein signature as diagnostic biomarker for resectable gastric cancer.一种靶向蛋白质组学方法揭示了一种血清蛋白质特征作为可切除胃癌的诊断生物标志物。
EBioMedicine. 2019 Jun;44:322-333. doi: 10.1016/j.ebiom.2019.05.044. Epub 2019 May 28.
10
25-HC decreases the sensitivity of human gastric cancer cells to 5-fluorouracil and promotes cells invasion via the TLR2/NF-κB signaling pathway.25-HC 通过 TLR2/NF-κB 信号通路降低人胃癌细胞对 5-氟尿嘧啶的敏感性并促进细胞侵袭。
Int J Oncol. 2019 Mar;54(3):966-980. doi: 10.3892/ijo.2019.4684. Epub 2019 Jan 11.

本文引用的文献

1
Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer.基质金属蛋白酶-1与食管癌的不良预后相关。
J Pathol. 1998 Jul;185(3):256-61. doi: 10.1002/(SICI)1096-9896(199807)185:3<256::AID-PATH115>3.0.CO;2-A.
2
Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.TIMP-1对人基质金属蛋白酶-1(基质溶解素-1)的抑制机制。
Nature. 1997 Sep 4;389(6646):77-81. doi: 10.1038/37995.
3
Computational sequence analysis of the tissue inhibitor of metalloproteinase family.金属蛋白酶组织抑制剂家族的计算序列分析
J Protein Chem. 1997 May;16(4):237-55. doi: 10.1023/a:1026348808069.
4
Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study.明胶酶A、金属蛋白酶组织抑制剂-2、基质溶素和胰蛋白酶(原)在肺肿瘤中的表达:一项免疫组织化学研究。
Hum Pathol. 1997 May;28(5):613-22. doi: 10.1016/s0046-8177(97)90085-x.
5
Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4.人金属蛋白酶组织抑制剂4的分子克隆与特性分析
J Biol Chem. 1996 Nov 29;271(48):30375-80. doi: 10.1074/jbc.271.48.30375.
6
Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system.核酶抑制基质金属蛋白酶9的表达可阻断大鼠肉瘤模型系统中的转移。
Cancer Res. 1996 Nov 15;56(22):5279-84.
7
Metalloproteinase inhibitors and the prevention of connective tissue breakdown.金属蛋白酶抑制剂与结缔组织分解的预防
Pharmacol Ther. 1996;70(3):163-82. doi: 10.1016/0163-7258(96)00015-0.
8
Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis.膜型基质金属蛋白酶(MT-MMPs)与肿瘤转移
J Biochem. 1996 Feb;119(2):209-15. doi: 10.1093/oxfordjournals.jbchem.a021223.
9
Matrix metalloproteinase inhibition: a review of anti-tumour activity.基质金属蛋白酶抑制作用:抗肿瘤活性综述
Ann Oncol. 1995 Dec;6(10):967-74. doi: 10.1093/oxfordjournals.annonc.a059091.
10
Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.基质金属蛋白酶MMP - 2和MMP - 9的组织水平与胃癌患者的总生存率相关。
Br J Cancer. 1996 Aug;74(3):413-7. doi: 10.1038/bjc.1996.374.